Global Polycystic Ovarian Syndrome Pcos Treatment Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 6.16 Billion |
 Market Size (Forecast Year) |
USD 9.81 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球多囊卵巢综合征 (PCOS) 治疗市场，按药物（口服避孕药、抗雄激素、胰岛素增敏剂、抗抑郁药、抗肥胖药）、手术（楔形切除术、腹腔镜钻孔术）、最终用户（医院、门诊手术中心等）划分 - 行业趋势和预测（至 2029 年）
全球多囊卵巢综合征 (PCOS) 治疗市场分析及规模
多囊卵巢综合征患病率的上升将推动多囊卵巢综合征 (PCOS) 治疗市场大幅增长，因为多囊卵巢综合征病例的增加将增加对有效治疗程序和药物的需求，从而对市场产生积极影响。根据美国疾病控制和预防中心的数据，大约有 500 万育龄妇女患有多囊卵巢综合征。因此，病例激增将直接为市场在预测期内实现丰厚增长提供机会。
- 2021 年全球多囊卵巢综合征 (PCOS) 治疗市场价值为 54.81 亿美元，预计到 2029 年将达到 87.3597 亿美元，在 2022-2029 年的预测期内复合年增长率为 6.0%。在预测期内，“腹腔镜卵巢打孔术”占多囊卵巢综合征 (PCOS) 治疗市场中最大的手术部分，因为它们是医生在危重情况下执行的最常见的手术。Data Bridge 市场研究团队策划的市场报告包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
全球多囊卵巢综合征 (PCOS) 治疗市场定义
多囊卵巢综合征 (PCOS) 是一种影响许多育龄妇女的激素疾病。多囊卵巢综合征 (PCOS) 的特征是月经周期不规律或延长以及雄性激素水平升高。虽然目前尚无治愈 PCOS 的方法，但许多药物可用于调节月经周期并控制该疾病的症状。它也是由高水平的雄激素、低度炎症、卵巢囊肿、胰岛素过量和遗传性疾病引起的。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
按药物（口服避孕药、抗雄激素、胰岛素增敏剂、抗抑郁药、抗肥胖药）、手术（楔形切除术、腹腔镜钻孔术）、最终用户（医院、门诊手术中心、其他） |
|
覆盖国家 |
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa |
|
Market Players Covered |
Bayer AG (Germany), Allergan (Ireland), Merck & Co. (U.S.), Pfizer Inc. (U.S.), Amgen (U.S.), Agile Therapeutics (U.S.), Ferring B.V (U.S.), Addex Therapeutics (Switzerland), Mylan N.V. (U.S.), Lupin (India), Blairex Laboratories Inc.,(U.S.), Apothecus Pharmaceutical Corp(U.S.), Eli Lilly And Company (U.S.), Novartis AG (Switzerland), BIOCAD Global (Russia), Teva Pharmaceutical Industries Ltd., (Israel) and Johnson & Johnson Services, Inc. (U.S.) |
|
Market Opportunities |
|
Polycystic Ovarian Syndrome (PCOS) Treatment Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Growing Burden Of Polycystic Ovarian Syndrome (PCOS)
The surging cases of polycystic ovarian syndrome (PCOS), across the world is the most significant factor driving the growth for this market. Additionally, the other factors, including rising prevalence of diabetes and obesity among women, increasing hormonal disorders in women, socioeconomic factors, change in sedentary lifestyle, and growing consumption of unhealthy diet, are also expected to accelerate the market's overall growth.
Furthermore, the expanding healthcare sector, adoption of combination drugs, and rising patient adoption are also expected to fuel market growth. Moreover, the rising awareness among the patients and doctors regarding the chronic diseases and hospital-acquired infections also cushions the market’s growth within the forecasted period. The focus of leading manufacturers on expanding their geographic presence is also projected to bolster the market's growth.
Opportunities
- Growing Investments and Advancements
Moreover, the technological advancements for detection of polycystic ovary syndrome and the growth in awareness about polycystic ovarian syndrome treatment are estimated to generate lucrative opportunities for the market. The untapped potential offered by developing economies combined with rise in adoption of polycystic ovarian syndrome treatment products will further offer numerous growth opportunities for the market.
Restraints/Challenges Global Polycystic Ovarian Syndrome (PCOS) Treatment Market
- Side Effects Associated With Drugs
The drugs for treating polycystic ovary syndrome also have various side effects. The side effects associated with drugs such as cardiovascular risks, weight gain, abnormal glucose tolerance, increase insulin resistance and thromboembolic events are expected to obstruct market growth.
- Stringent Drug Approval Policies
Also, the lack of approved therapeutics and lack of FDA drug approval is projected to challenge the polycystic ovarian syndrome (PCOS) treatment market in the forecast period of 2022-2029.
Furthermore, the lack of specific treatment for this disorder along with the unknown etiology and pathophysiology of polycystic ovarian syndrome will also hamper overall growth for the market.
This polycystic ovarian syndrome (PCOS) treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the polycystic ovarian syndrome (PCOS) treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post Covid-19 Impact on Polycystic Ovarian Syndrome (PCOS) Treatment Market
Healthcare industry was largely impacted by the outbreak of COVID-19. The polycystic ovarian syndrome (PCOS) treatment market does not stand back as it was also adversely affected by it as pandemic had repercussions for many surgical operations, including laparoscopic ovarian drilling The imposition of the lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, led to halt of various operations, supply chain disruptions, stifling business growth, suspensions of new developments and has affected the overall treatment procedure which have impacted the market negatively. The non-essential treatment surgeries or procedures were also suspended. According to Experts at the University of Birmingham, patients who have contracted coronavirus and undertake surgery are at an increased risk of postoperative mortality, and that all non-emergent surgeries should be avoided. However, to maintain normal surgical practices, regulatory authorities established a few guidelines unique to each profession that surgeons must implement and follow to continue to offer safe and effective care to their patients throughout the COVID-19 pandemic.
On the brighter side, with the decrease in COVID-19 patients, the restrictions of the government measures are likely to relax. This will help the market witness a slight increment post COVID-19, as normal surgical practices can occur according to few guidelines that surgeons must implement and follow to continue to offer safe and effective care to their patients throughout. Healthcare practitioners have been able to restart their surgery practices as a result of the new standards. As a result, it is envisaged that laparoscopic ovarian drilling treatments will resume their usual growth post- COVID.
Recent Developments
- In January 2020, Abbvie had a clinical trial in the works with the chemical Elagolix, which is being tested for safety and efficacy in women with polycystic ovary syndrome. The business is now conducting a Phase 2 multicenter, double-blind, randomised, placebo-controlled research to evaluate Elagolix's safety and efficacy in women with polycystic ovarian syndrome (PCOS).
- In Jan 2020, Evotec SE and Bayer AG launched a new five-year multi-target collaboration with Celmatix Inc. to develop various clinical candidates for the treatment of polycystic ovarian syndrome, which is projected to drive the market during the forecast period.
Global Polycystic Ovarian Syndrome (PCOS) Treatment Market Scope
The polycystic ovarian syndrome (PCOS) treatment market is segmented on the basis of drugs, surgery and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drugs
- Oral Contraceptives
- Antiandrogen
- Insulin-Sensitizing Agents
- Antidepressants
- Anti-Obesity
On the basis of drugs, the polycystic ovarian syndrome (PCOS) treatment market is segmented into oral contraceptives, antiandrogen, insulin-sensitizing agents, antidepressants and anti-obesity.
Surgery
- Wedge Resection
- Laparoscopic Drilling
On the basis of surgery, the polycystic ovarian syndrome (PCOS) treatment market is segmented into wedge resection and laparoscopic drilling. Laparoscopic ovarian drilling is expected to register a major share in the market as they are the most common surgeries performed by doctors in critical conditions.
End User
- Hospital
- Ambulatory Surgical Centers
- Others
On the basis of end user, the polycystic ovarian syndrome (PCOS) treatment market is bifurcated into hospital, ambulatory surgical centers and others.
Polycystic Ovarian Syndrome (PCOS) Treatment Market Regional Analysis/Insights
The polycystic ovarian syndrome (PCOS) treatment market is analyzed and market size insights and trends are provided by country, drugs, surgery and end user as referenced above.
The countries covered in the polycystic ovarian syndrome (PCOS) treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the polycystic ovarian syndrome (PCOS) treatment market because of the high awareness and the availability of advanced healthcare facilities within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the government initiatives to raise awareness about the symptoms and diagnosis of PCOS and available treatment, which are increasing the number of women diagnosed with this syndrome within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The polycystic ovarian syndrome (PCOS) treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for polycystic ovarian syndrome (PCOS) treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the polycystic ovarian syndrome (PCOS) treatment market. The data is available for historic period 2010-2020.
Competitive Landscape and Polycystic Ovarian Syndrome (PCOS) Treatment Market Share Analysis
多囊卵巢综合征 (PCOS) 治疗市场竞争格局提供了按竞争对手划分的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对多囊卵巢综合征 (PCOS) 治疗市场的关注有关。
多囊卵巢综合征 (PCOS) 治疗市场的一些主要参与者包括
- 拜耳公司（德国）
- 艾尔建（爱尔兰）
- 默克公司 (美国)
- 辉瑞公司 (美国)
- 安进（美国）
- Agile Therapeutics（美国）
- Ferring BV（美国）
- Addex Therapeutics（瑞士）
- Mylan NV（美国）
- 鲁冰花（印度）
- Blairex Laboratories Inc（美国）
- Apothecus Pharmaceutical Corp（美国）
- 礼来公司（美国）
- 诺华公司（瑞士）
- BIOCAD Global（俄罗斯）
- 梯瓦制药工业有限公司 (以色列)
- 强生服务公司（美国）
研究方法：全球多囊卵巢综合征 (PCOS) 治疗市场
数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息，请请求分析师致电或下拉询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请咨询我们的行业专家 https://www.databridgemarketresearch.com/zh/speak-to-analyst/?dbmr=global-polycystic-ovarian-syndrome-pcos-treatment-market
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
